Source:http://linkedlifedata.com/resource/pubmed/id/10189189
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-5-28
|
pubmed:abstractText |
Human (h) interleukin-10 (IL-10) exhibits a strong DNA and amino acid sequence homology to the Epstein-Barr virus (EBV) BCRF1 genome, viral (v) IL-10. We analyzed the production of IL-10 for EBV activation in B-cell lines. The latent EBV in Akata cells was activated by the cross-linking of surface immunoglobulin G (IgG) with anti-human IgG. The levels of IL-10(h+v) and vIL-10 in the culture fluids were measured by a specific enzyme-linked immunosorbent assay (ELISA). IL-10(h+v) was detected at the same time for EBV immediate early gene BZLF1 product ZEBRA and early gene BMRF1 product EA-D. This was more than 4 hours prior to the appearance of vIL-10, and late gene products gp 350/220 and viral capsid antigen. The induction of hIL-10 and vIL-10 mRNAs were detected in anti-IgG-treated Akata cells by reverse transcription-polymerase chain reaction. The induction of IL-10(h+v) and vIL-10 was inhibited with a tyrosine kinase inhibitor, herbimycin, or with an inhibitor of herpesvirus DNA polymerase, phosphonoacetic acid, or acyclovir. IL-10(h+v) and vIL-10 were also detected in the supernatants of Akata and Daudi but not Ramos cells infected with P3HR-1 EBV. These results show the IL-10 induction on EBV activation in EBV-carrying B-cell lines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acyclovir,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonoacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0882-8245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-31
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10189189-Acyclovir,
pubmed-meshheading:10189189-Antiviral Agents,
pubmed-meshheading:10189189-B-Lymphocytes,
pubmed-meshheading:10189189-Cell Line,
pubmed-meshheading:10189189-Gene Expression,
pubmed-meshheading:10189189-Herpesvirus 4, Human,
pubmed-meshheading:10189189-Humans,
pubmed-meshheading:10189189-Immunoglobulin G,
pubmed-meshheading:10189189-Interleukin-10,
pubmed-meshheading:10189189-Phosphonoacetic Acid,
pubmed-meshheading:10189189-Protein-Tyrosine Kinases,
pubmed-meshheading:10189189-RNA, Messenger,
pubmed-meshheading:10189189-Virus Activation
|
pubmed:year |
1998
|
pubmed:articleTitle |
Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines.
|
pubmed:affiliation |
Department of Biosignaling, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|